Articles with the topic: phosphodiesterase

Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms

Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms

Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD

Dr Ed WildDecember 16, 2016

'Buzzilia' from the Huntington's Disease World Congress: day 1

'Buzzilia' from the Huntington's Disease World Congress: day 1

Buzzilia, day 1: Jeff and Ed's roundup of happenings from the opening day of the HD World Congress in Rio de Janeiro

Dr Ed WildSeptember 15, 2013

Video: What’s new in Huntington's disease research 2012

Video: What’s new in Huntington's disease research 2012

Watch Ed Wild's address to the European Huntington's Association on how HD research works and the most promising poss

Dr Ed WildOctober 10, 2012

Phosphodiesterase inhibitors: new HD drugs entering trials soon

Phosphodiesterase inhibitors: new HD drugs entering trials soon

CHDI and Pfizer announce exciting animal work and plans for a human trial with a drug targeting 'phosphodiesterases'.

Carly DesmondJune 07, 2012